NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infectives, today reported second quarter 2014 financial results and provided a clinical and commercialization update.
“In July, we announced a major marketing and commercialization campaign for the company’s new product, i-LidTMCleanser. The effort is led by Glenn Moro, our new Vice President of Sales and Marketing, who has a long and successful track record of launching products in this ophthalmology and optometry space,” commented Ron Najafi, Ph.D., Chairman and CEO of NovaBay Pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.